Stocks in Focus: API Technologies (NASDAQ:ATNY), Intercept Pharmaceuticals (NASDAQ:ICPT), OvaScience (NASDAQ:OVAS), Charles & Colvard Ltd. (NASDAQ:CTHR)

API Technologies Corp. (NASDAQ:ATNY), a leading provider of high performance RF/microwave, power, and security solutions for critical and high-reliability applications, announced today the launch of configurable frequency synthesizers (Models LCFS-X), the newest addition to the Company’s line of standard RF / microwave products. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is 0.00%. On last trading day company shares ended up $2.06. API Technologies Corp. (NASDAQ:ATNY) distance from 50-day simple moving average (SMA50) is -15.77%.

Intercept Pharmaceuticals Inc. (ICPT) reported second quarter EPS of $1.51 after the close Monday, compared to the loss of $0.79 in the prior year period. Analysts had expected a loss of $0.12 per share. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares advanced 16.59% in last trading session and ended the day at $276.52. ICPT return on assets is -205.10%. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) quarterly performance is 6.58%.

OvaScience, Inc. (NASDAQ:OVAS) currently has a Zacks Rank #3 (Hold). On 12 August, OvaScience, Inc. (NASDAQ:OVAS) shares advanced 1.20% and was closed at $10.94. OVAS EPS growth in last 5 year was 0.00%. OvaScience, Inc. (NASDAQ:OVAS) year to date (YTD) performance is 19.69%.

Charles & Colvard (NASDAQ:CTHR) Director Anne M. Butler purchased 35,800 shares of Charles & Colvard stock on the open market in a transaction that occurred on Monday, August 11th. The stock was purchased at an average cost of $1.89 per share, for a total transaction of $67,662.00. Following the completion of the acquisition, the director now directly owns 112,581 shares of the company’s stock, valued at approximately $212,778. The purchase was disclosed in a filing with the SEC. Charles & Colvard Ltd. (NASDAQ:CTHR) shares advanced 2.09% in last trading session and ended the day on $1.95. CTHR Gross Margin is 41.20% and its return on assets is -13.50%. Charles & Colvard Ltd. (NASDAQ:CTHR) quarterly performance is -9.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone